| Patients’ characteristics |
Number of patients (%) (Total=181) |
Sex
Male
Female |
102 (56,3%)
79 (43,7%) |
Age
Median (Range) |
65 years (38-84) |
Stage of cancer at first presentation
I
II
III
IV
Locally advanced vs metastatic at study enrollment |
6 (3,3%)
22 (12,2%)
55 (30,4%)
98 (54,1%)
146/181 (80,7%/19.3%) |
Site of metastases
Liver
Lung
Peritoneum
Loco-regional
Other |
66 (67,3%)
4 (4,1%)
12 (12,2%)
13 (3,1%)
3 (13,3%) |
Performance Status ECOG
0
1
2
3 |
90 (49,7%)
69 (38,1%)
19 (10,5%)
3 (1,7%) |
| Follow up Median (range) |
8,51 months (0,39-66,1) |
Deaths
Yes
No |
147 (81,2%)
34 (18,8%) |
|
